Cargando…

BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer

Inflammation might substantially contribute to the limited therapeutic success of current systemic therapies in colorectal cancer (CRC). Amongst cytokines involved in CRC biology, the proinflammatory chemokine IL-8 has recently emerged as a potential prognostic/predictive biomarker. Here, we show th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conciatori, Fabiana, Bazzichetto, Chiara, Amoreo, Carla Azzurra, Sperduti, Isabella, Donzelli, Sara, Diodoro, Maria Grazia, Buglioni, Simonetta, Falcone, Italia, Shirasawa, Senji, Blandino, Giovanni, Ferretti, Gianluigi, Cognetti, Francesco, Milella, Michele, Ciuffreda, Ludovica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530707/ https://www.ncbi.nlm.nih.gov/pubmed/33004975 http://dx.doi.org/10.1038/s42003-020-01263-y

Ejemplares similares

Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition
por: Conciatori, Fabiana, et al.
Publicado: (2022)

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
por: Falcone, Italia, et al.
Publicado: (2020)

Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
por: Conciatori, Fabiana, et al.
Publicado: (2019)

Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
por: Del Curatolo, Anais, et al.
Publicado: (2018)

PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy
por: Conciatori, Fabiana, et al.
Publicado: (2020)

mTOR Cross-Talk in Cancer and Potential for Combination Therapy
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
por: Falcone, Italia, et al.
Publicado: (2020)

From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker
por: Bazzichetto, Chiara, et al.
Publicado: (2022)

Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

PTEN: Multiple Functions in Human Malignant Tumors
por: Milella, Michele, et al.
Publicado: (2015)

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
por: Milella, Michele, et al.
Publicado: (2017)

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
por: Valenti, Fabio, et al.
Publicado: (2021)

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
por: Loria, Rossella, et al.
Publicado: (2022)

MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer
por: Stramucci, Lorenzo, et al.
Publicado: (2019)

Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
por: Bon, Giulia, et al.
Publicado: (2016)

TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
por: Dinami, Roberto, et al.
Publicado: (2020)

BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells
por: Goulielmaki, Maria, et al.
Publicado: (2016)

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors
por: Ugel, Stefano, et al.
Publicado: (2023)

Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
por: Allegretti, Matteo, et al.
Publicado: (2020)

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
por: Gkountakos, Anastasios, et al.
Publicado: (2019)

Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer
por: Goeman, Frauke, et al.
Publicado: (2020)

BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study
por: Makrodouli, Eleni, et al.
Publicado: (2011)

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2019)

Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer
por: De Nicola, Francesca, et al.
Publicado: (2018)

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
por: Pallocca, Matteo, et al.
Publicado: (2018)

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
por: Loupakis, Fotios, et al.
Publicado: (2010)

The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response
por: Martelli, Alberto M., et al.
Publicado: (2019)

Identification of KRAP-expressing cells and the functional relevance of KRAP to the subcellular localization of IP(3)R in the stomach and kidney
por: FUJIMOTO, TAKAHIRO, et al.
Publicado: (2012)

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
por: Melucci, Elisa, et al.
Publicado: (2018)

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
por: Novelli, Flavia, et al.
Publicado: (2008)

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
por: D’Aguanno, Simona, et al.
Publicado: (2018)

Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab
por: Campanella, Carla, et al.
Publicado: (2010)

In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
por: Bordonaro, Michael, et al.
Publicado: (2016)

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
por: Cuppone, Federica, et al.
Publicado: (2011)

Pretreated EGFR(del19)/BRAF(V600E) Lung Adenocarcinoma With Leptomeningeal Disease Achieving Long-Lasting Disease Control on Osimertinib, Dabrafenib, and Trametinib: A Case Report
por: Orciuolo, Corrado, et al.
Publicado: (2023)

TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment
por: Zizza, Pasquale, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7r43jgla0ipeeek3cm824qpson